• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阑尾黏液性肿瘤伴腹膜播散的分期定义:分级术语的重要性:系统评价。

Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review.

机构信息

Peritoneal Carcinomatosis Unit, Department of General and Digestive Surgery, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Department of Surgery, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain.

出版信息

BJS Open. 2021 Jul 6;5(4). doi: 10.1093/bjsopen/zrab059.

DOI:10.1093/bjsopen/zrab059
PMID:34355239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8342933/
Abstract

BACKGROUND

Mucinous appendiceal neoplasms with peritoneal dissemination (PD) show a wide spectrum of clinical behaviour. Histological grade has been correlated with prognosis, but no universally accepted histological grading has been established. The aim of this systematic review was to provide historical insight to understand current grading classifications, basic histopathological features of each category, and to define which classification correlates best with prognosis.

METHODS

MEDLINE and the Cochrane Library were searched for studies that reported survival across different pathological grades in patients with mucinous neoplasm of the appendix with PD treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. PRISMA guidelines were followed.

RESULTS

Thirty-eight studies were included. Ronnett's classification was the most common (9 studies). Classifications proposed by the Peritoneal Surface Oncology Group International (PSOGI) (6 studies) and the seventh or eighth edition of the AJCC (7 studies) are gaining in popularity. Nine studies supported a two-tier, 12 a three-tier, and two a four-tier classification system. Three studies demonstrated that acellular mucin had a better prognosis than low-grade pseudomyxoma peritonei in the PSOGI classification or M1bG1 in the eighth edition of the AJCC classification. Four studies demonstrated that the presence of signet ring cells was associated with a worse outcome than high-grade pseudomyxoma peritonei in the PSOGI classification and M1bG2 in the eighth edition of the AJCC.

CONCLUSION

There is a great need for a common language in describing mucinous neoplasms of the appendix with PD. Evolution in terminology as a result of pathological insight turns the four-tiered PSOGI classification system into a coherent classification option.

摘要

背景

具有腹膜播散(PD)的黏液性阑尾肿瘤具有广泛的临床行为谱。组织学分级与预后相关,但尚未建立普遍接受的组织学分级标准。本系统评价的目的是提供历史见解,以了解当前的分级分类,每种类别的基本组织病理学特征,并确定哪种分类与预后相关性最好。

方法

在 MEDLINE 和 Cochrane 图书馆中搜索了报道黏液性阑尾肿瘤伴 PD 患者接受细胞减灭术和腹腔内热化疗后不同病理分级生存情况的研究。遵循 PRISMA 指南。

结果

共纳入 38 项研究。Ronnett 分类最常见(9 项研究)。腹膜表面肿瘤国际组织(PSOGI)提出的分类(6 项研究)和 AJCC 第 7 或第 8 版(7 项研究)越来越受欢迎。9 项研究支持两阶梯、12 项三阶梯和两项四阶梯分类系统。三项研究表明,在 PSOGI 分类中无细胞黏液比低级别腹膜假黏液瘤或 AJCC 第 8 版分类中的 M1bG1 具有更好的预后。四项研究表明,在 PSOGI 分类中,PSOGI 分类中存在印戒细胞比高级别腹膜假黏液瘤或 AJCC 第 8 版中的 M1bG2 预后更差。

结论

需要一种通用语言来描述具有 PD 的黏液性阑尾肿瘤。由于病理见解的发展,术语的演变使四阶梯 PSOGI 分类系统成为一种连贯的分类选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ba/8342933/3d49ba9aec16/zrab059f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ba/8342933/3d49ba9aec16/zrab059f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21ba/8342933/3d49ba9aec16/zrab059f2.jpg

相似文献

1
Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review.阑尾黏液性肿瘤伴腹膜播散的分期定义:分级术语的重要性:系统评价。
BJS Open. 2021 Jul 6;5(4). doi: 10.1093/bjsopen/zrab059.
2
Which classification system defines best prognosis of mucinous neoplasms of the appendix with peritoneal dissemination: TNM vs PSOGI?哪种分类系统能最好地定义伴有腹膜播散的阑尾黏液性肿瘤的预后:TNM还是PSOGI?
J Clin Pathol. 2023 Apr;76(4):266-273. doi: 10.1136/jclinpath-2021-207883. Epub 2021 Nov 1.
3
Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.对接受细胞减灭术和腹腔热灌注化疗治疗的 265 例患者的单中心系列进行的最近的 PSOGI 病理分类对假性黏液瘤腹膜的验证。
Ann Surg Oncol. 2018 Feb;25(2):404-413. doi: 10.1245/s10434-017-6252-1. Epub 2017 Nov 20.
4
Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.阑尾肿瘤和腹膜假黏液瘤:文献综述及 PSOGI/EURACAN 诊断和治疗临床实践指南。
Eur J Surg Oncol. 2021 Jan;47(1):11-35. doi: 10.1016/j.ejso.2020.02.012. Epub 2020 Feb 28.
5
A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.腹膜假黏液瘤及相关阑尾肿瘤的分类与病理报告共识:国际腹膜表面肿瘤学组(PSOGI)改良德尔菲法的结果
Am J Surg Pathol. 2016 Jan;40(1):14-26. doi: 10.1097/PAS.0000000000000535.
6
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?细胞减灭术和腹腔内热化疗治疗老年患者的假性黏液瘤和阑尾肿瘤:是否合理?
Clin Transl Oncol. 2017 Nov;19(11):1388-1392. doi: 10.1007/s12094-017-1728-9. Epub 2017 Aug 10.
7
An Update on the Diagnosis, Grading, and Staging of Appendiceal Mucinous Neoplasms.阑尾黏液性肿瘤的诊断、分级和分期的更新。
Adv Anat Pathol. 2018 Jan;25(1):38-60. doi: 10.1097/PAP.0000000000000178.
8
Hyperthermic intraperitoneal chemotherapy with oxaliplatin as treatment for peritoneal carcinomatosis arising from the appendix and pseudomyxoma peritonei: a survival analysis.以奥沙利铂进行热灌注腹腔化疗治疗阑尾来源的腹膜癌病和腹膜假黏液瘤:一项生存分析
World J Surg Oncol. 2014 Nov 7;12:332. doi: 10.1186/1477-7819-12-332.
9
Correlation between PSOGI pathological classification and survival outcomes of patients with pseudomyxoma peritonei treated using cytoreductive surgery and HIPEC: national referral centre experience and literature review.腹膜假黏液瘤患者接受细胞减灭术和腹腔热灌注化疗治疗时PSOGI病理分类与生存结果的相关性:国家转诊中心经验及文献综述
Pleura Peritoneum. 2023 May 1;8(2):65-74. doi: 10.1515/pp-2023-0001. eCollection 2023 Jun.
10
Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).黏液性和非黏液性阑尾肿瘤伴腹膜转移行细胞减灭术和腹腔热灌注化疗(HIPEC)的对比研究。
Eur J Surg Oncol. 2021 May;47(5):1132-1139. doi: 10.1016/j.ejso.2020.08.017. Epub 2020 Aug 25.

引用本文的文献

1
Appendiceal Mucinous Neoplasms: From Clinic to Pathology and Prognosis.阑尾黏液性肿瘤:从临床到病理及预后
Cancers (Basel). 2023 Jun 30;15(13):3426. doi: 10.3390/cancers15133426.
2
Misdiagnosed appendiceal mucinous neoplasms and primary ovarian mucinous tumors present with different pre- and intraoperative characteristics.误诊的阑尾黏液性肿瘤和原发性卵巢黏液性肿瘤具有不同的术前和术中特征。
Front Oncol. 2022 Aug 25;12:966844. doi: 10.3389/fonc.2022.966844. eCollection 2022.

本文引用的文献

1
Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.阑尾肿瘤和腹膜假黏液瘤:文献综述及 PSOGI/EURACAN 诊断和治疗临床实践指南。
Eur J Surg Oncol. 2021 Jan;47(1):11-35. doi: 10.1016/j.ejso.2020.02.012. Epub 2020 Feb 28.
2
The prognostic relevance of histologic subtype in appendiceal adenocarcinoma.阑尾腺癌组织学亚型的预后相关性。
Eur J Surg Oncol. 2020 Mar;46(3):433-438. doi: 10.1016/j.ejso.2019.10.018. Epub 2019 Oct 15.
3
Should We Be Doing Cytoreductive Surgery with HIPEC for Signet Ring Cell Appendiceal Adenocarcinoma? A Study from the US HIPEC Collaborative.
我们是否应该对印戒细胞阑尾腺癌行细胞减灭术联合腹腔热灌注化疗?来自美国 HIPEC 协作组的一项研究。
J Gastrointest Surg. 2020 Jan;24(1):155-164. doi: 10.1007/s11605-019-04336-4. Epub 2019 Aug 19.
4
Surveillance of Low-Grade Appendiceal Mucinous Neoplasms With Peritoneal Metastases After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Are 5 Years Enough? A Multisite Experience.黏液性低级别阑尾肿瘤患者行细胞减灭术和腹腔热灌注化疗后发生腹膜转移的监测:5 年足够吗?多中心经验。
Ann Surg Oncol. 2020 Jan;27(1):147-153. doi: 10.1245/s10434-019-07678-0. Epub 2019 Aug 5.
5
Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms.影响阑尾肿瘤来源的假性黏液瘤经细胞减灭术和腹腔热灌注化疗后长期生存的因素。
BJS Open. 2019 Feb 19;3(3):376-386. doi: 10.1002/bjs5.50134. eCollection 2019 Jun.
6
Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis.以奥沙利铂进行腹腔热灌注化疗治疗阑尾腹膜癌病后的长期生存分析
Surg Oncol. 2019 Mar;28:69-75. doi: 10.1016/j.suronc.2018.11.006. Epub 2018 Nov 13.
7
Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms.阑尾上皮性肿瘤的细胞减灭术及腹腔内热灌注化疗的疗效
ANZ J Surg. 2019 Sep;89(9):1035-1040. doi: 10.1111/ans.14985. Epub 2019 Jan 26.
8
Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.阑尾印戒细胞癌伴腹膜转移行细胞减灭术和腹腔热灌注化疗的结局。
Ann Surg Oncol. 2019 Feb;26(2):473-481. doi: 10.1245/s10434-018-7007-3. Epub 2018 Dec 6.
9
Histologic Predictors of Recurrence in Mucinous Appendiceal Tumors with Peritoneal Dissemination after HIPEC.HIPEC 后腹膜播散性黏液性阑尾肿瘤的组织学预测因子
Ann Surg Oncol. 2018 Mar;25(3):702-708. doi: 10.1245/s10434-017-6310-8. Epub 2017 Dec 27.
10
Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.对接受细胞减灭术和腹腔热灌注化疗治疗的 265 例患者的单中心系列进行的最近的 PSOGI 病理分类对假性黏液瘤腹膜的验证。
Ann Surg Oncol. 2018 Feb;25(2):404-413. doi: 10.1245/s10434-017-6252-1. Epub 2017 Nov 20.